Page 54 - JCTR-9-5

356 Iyngkaran et al. | Journal of Clinical and Translational Research 2023; 9(5): 347-356
[33] Zizola C, Schulze PC. Metabolic and Structural Impairment [42] Umaefulam V, Kleissen T, Barnabe C. The Representation
of Skeletal Muscle in Heart Failure. Heart Fail Rev of Indigenous Peoples in Chronic Disease Clinical Trials
2013;18:623-30. in Australia, Canada, New Zealand, and the United States.
[34] Iyngkaran P, Liew D, Neil C, Driscoll A, Marwick TH, Clin Trials 2022;19:22-32.
Hare DL. Moving from Heart Failure Guidelines to [43] Whyte J. Racial and Ethnic Representation of Participants
Clinical Practice: Gaps Contributing to Readmissions in in US Clinical Trials of New Drugs and Biologics. JAMA
Patients with Multiple Comorbidities and Older Age. Clin 2022;327:985.
Med Insights Cardiol 2018;12:1179546818809358. [44] Gray LA, D’Antoine HA, Tong SY, McKinnon M,
[35] Iyngkaran P, Liew D, McDonald P, Thomas MC, Reid C, Bessarab D, Brown N, et al. Genome-Wide Analysis
Chew D, et al. Phase 4 Studies in Heart Failure-what is done of Genetic Risk Factors for Rheumatic Heart Disease in
and what is Needed? Curr Cardiol Rev 2016;12:216-30. Aboriginal Australians Provides Support for Pathogenic
[36] Atkinson J. Cardiovascular and Smooth Muscle Molecular Mimicry. J Infect Dis 2017;216:1460-70.
Pharmacology in the Next Decade. Front Pharmacol [45] Spence JD, Rayner BL. Hypertension in Blacks:
2010;1:1. Individualized Therapy Based on Renin/Aldosterone
[37] G-CHF Investigators, Joseph P, Roy A, Lonn E, Störk S, Phenotyping. Hypertension 2018;72:263-9.
Floras J, et al. Global Variations in Heart Failure Etiology, [46] Savoia C, Volpe M, Grassi G, Borghi C, Agabiti Rosei E,
Management, and Outcomes. JAMA 2023;329:1650-61. Touyz RM. Personalized Medicine-a Modern Approach for
[38] Radhoe SP, Veenis JF, Brugts JJ. Invasive Devices and the Diagnosis and Management of Hypertension. Clin Sci
Sensors for Remote Care of Heart Failure Patients. Sensors (Lond) 2017;131:2671-85.
(Basel) 2021;21:2014. [47] Volpp KG, Krumholz HM, Asch DA. Mass Customization
[39] Iyngkaran P, Thomas MC, Johnson R, French J, Ilton M, for Population Health. JAMA Cardiol 2018;3:363-4.
McDonald P, et al. Contextualizing Genetics for Regional [48] Semsarian C, Ingles J, Ross SB, Dunwoodie SL,
Heart Failure Care. Curr Cardiol Rev 2016;12:231-42. Bagnall RD, Kovacic JC. Precision Medicine in
[40] Nanayakkara S, Marwick TH, Kaye DM. The Ageing Cardiovascular Disease: Genetics and Impact on
Heart: The Systemic and Coronary Circulation. Heart Phenotypes: JACC Focus Seminar 1/5. J Am Coll Cardiol
2018;104:370-6. 2021;77:2517-30.
[41] Lam CS, Arnott C, Beale AL, Chandramouli C, Hilfiker- [49] Leopold JA, Loscalzo J. Emerging Role of Precision
Kleiner D, Kaye DM, et al. Sex Differences in Heart Medicine in Cardiovascular Disease. Circ Res
Failure. Eur Heart J 2019;40:3859-68c. 2018;122:1302-15.

Publisher’s note
AccScience Publishing remains neutral with regard to jurisdictional
claims in published maps and institutional affiliations.
DOI: http://dx.doi.org/10.18053/jctres.09.202305.23-00010